Wuxi Hyatech Co (688510.SS) Stock Price

Wuxi Hyatech Co Price

CLOSED
19.81
​
Market closed

Over the last 11 years Wuxi Hyatech Co grew revenue by 91.1% annually, reaching 698.67 M CNY. Earnings per share have grown at 28.7% per year over the last 7 years. For Wuxi Hyatech Co, the net margin of 14.6% is up versus 7.8% a few years ago. At today's price the dividend yield works out to roughly 1.01%. The payout ratio is around 48% of earnings. The dividend has grown at 26.0% per year over the past 3 years. The consensus 12-month price target for Wuxi Hyatech Co is 30.29 CNY, about 52.9% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Wuxi Hyatech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co business model & stock analysis

Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production.

Frequently asked questions about Wuxi Hyatech Co

Analysts currently set an average price target of 30.29 CNY for the Wuxi Hyatech Co stock (median: 30.29 CNY), implying +55.9 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Wuxi Hyatech Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Wuxi Hyatech Co to generate revenue of 807.00 M CNY and earnings per share of 0.54 CNY.

Converted at the current exchange rate, the Wuxi Hyatech Co share trades at 2.66 EUR (19.81 CNY).

The expected revenue of Wuxi Hyatech Co is 807.00 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Wuxi Hyatech Co is 132.36 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Wuxi Hyatech Co is currently 36.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Wuxi Hyatech Co stock.

The price-to-sales ratio (P/S) of Wuxi Hyatech Co is currently 6.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Wuxi Hyatech Co stock.

The Eulerpool Quality Score for Wuxi Hyatech Co is 6/10.

The ISIN of Wuxi Hyatech Co is CNE1000077M3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Wuxi Hyatech Co is 688510.SS. The ticker symbol is used to trade Wuxi Hyatech Co shares on the stock exchange.

Fair ValueTerminal
20.80 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Aerospace & Defense
Number of shares
Employees
Revenue per Employee
1.06 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hyatech.cn
Country
Currency
CNY
Initial public offering
Dec 16, 2020
ISIN
CNE1000077M3
Cusip
Y971KS101
Market capitalization
5.14 B CNYMid Cap
52-Week Range
PEG
2.11
P/E ratio
P/Ee 2026
38.84
P/Ee 2027
26.07
P/Ee 2028
21.07
P/S
P/Se
6.04
EV/EBIT
43.71
P/B Ratio
4.26
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.82 %
Dividend
Dividend yield
1.01 %
Est. Dividend Yield
1.01 %
Payout Ratio
48.21 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 30, 2026, 9:58 PM

Wuxi Hyatech Co Peer Group